ARTICLE | Clinical News
Zerbaxa ceftolozane/tazobactam regulatory update
August 3, 2015 7:00 AM UTC
EMA’s CHMP recommended approval of Zerbaxa ceftolozane/tazobactam to treat complicated intra-abdominal infections (cIAIs), acute pyelonephritis and complicated urinary tract infections (cUTIs). The co...